RTTNews | Oct 7, 2020 10:41AM EDT

10:41 Wednesday, October 7, 2020 (RTTNews.com) - Enlivex Therapeutics Ltd. (ENLV) shares are sliding more than 12 percent on Wednesday morning, despite no specific announcement from the company.

Currently, the shares are at $12.71, down 12.31 percent from its previous close of $14.50. The shares have traded in a range of $3.59 to $16.94 on average volume of 962,601. The clinical-stage immunotherapy company had reported positive results for its investigator-initiated clinical trial of Allocetra in COVID-19 patients in severe or critical condition on October 1. The shares have been trading higher since then, however, started to slide this morning

Read the original article on RTTNews ( https://www.rttnews.com/3134536/stock-alert-enlivex-therapeutics-down-12.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved